m+Medelevator.RU
← Поиск публикаций
Angewandte Chemie (International ed. in English) · 2025

A General Strategy to Access Pharmaceutically Relevant Pyridines from Nitroarenes.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Saha Argha, Pan Avishek, Ghosh Devika, Pal Anirban, Guin Srimanta, Redhu Archana Kumari, Gota Vikram, Maiti Debabrata

Аннотация

The incorporation of nitrogen atoms into aromatic systems is a cornerstone of modern drug design, enabling precise modulation of molecular properties and enhanced bioactivity. Here, we report a general and efficient strategy for the first-time conversion of nitroarenes into pharmaceutically relevant pyridine heterocycles via a nitrene-mediated transformation. This process is driven by a bio-inspired iron-porphyrin catalyst that uniquely serves as a singlet oxygen reservoir, enabling the formation of aminopyridines via C5-carbon deletion through a controlled ring-editing cascade. The unprecedented selective C5-carbon deletion provides a powerful new retrosynthetic logic for heterocycle construction. The reaction proceeds under mild conditions, tolerates a wide range of functional groups, and offers broad substrate scope with high regioselectivity. Furthermore, the method's ability to efficiently convert nitroarenes into bioactive pyridine scaffolds via ipso-carbon deletion underscores its practicality and step economy. This modular platform also streamlines the synthesis of drug-like scaffolds from simple building blocks, as demonstrated by the late-stage functionalization of nimesulide derivatives with improved molecular docking and binding profiles. Overall, this work showcases a distinctive catalytic paradigm for heterocycle construction with direct implications for pharmaceutical development and molecular remodeling.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты